2025-11-14T08:01:10.960100

Infectious diseases, imposing density-dependent mortality on MHC/HLA variation, can account for balancing selection and MHC/HLA polymorphism

Green
The human MHC transplantation loci (HLA-A, -B, -C, -DPB1, -DQB1, -DRB1) are the most polymorphic in the human genome. It is generally accepted this polymorphism reflects a role in presenting pathogen-derived peptide to the adaptive immune system. Proposed mechanisms for the polymorphism such as negative frequency-dependent selection (NFDS) and heterozygote advantage (HA) focus on HLA alleles, not haplotypes. Here, we propose a model for the polymorphism in which infectious diseases impose independent density-dependent regulation on HLA haplotypes. More specifically, a complex pathogen environment drives extensive host polymorphism through a guild of HLA haplotypes that are specialised and show incomplete peptide recognition. Separation of haplotype guilds is maintained by limiting similarity. The outcome is a wide and stable range of haplotype densities at steady-state in which effective Fisher fitnesses are zero. Densities, and therefore frequencies, emerge theoretically as alternative measures of fitness. A catalogue of ranked frequencies is therefore one of ranked fitnesses. The model is supported by data from a range of sources including a Caucasian HLA dataset compiled by the US National Marrow Donor Program (NMDP). These provide evidence of positive selection on the top 350-2000 5-locus HLA haplotypes taken from an overall NMDP sample set of 10E5. High-fitness haplotypes drive the selection of 137 high-frequency alleles spread across the 5 HLA loci under consideration. These alleles demonstrate positive epistasis and pleiotropy in the formation of haplotypes. Allelic pleiotropy creates a network of highly inter-related HLA haplotypes that account for 97% of the census sample. We suggest this network has properties of a quasi-species and is itself under selection. We also suggest this is the origin of balancing selection in the HLA system.
academic

๊ฐ์—ผ์„ฑ ์งˆํ™˜์ด MHC/HLA ๋ณ€์ด์— ๋ฐ€๋„ ์˜์กด์  ์‚ฌ๋ง๋ฅ ์„ ๋ถ€๊ณผํ•จ์œผ๋กœ์จ ๊ท ํ˜• ์„ ํƒ๊ณผ MHC/HLA ๋‹คํ˜•์„ฑ์„ ์„ค๋ช…ํ•  ์ˆ˜ ์žˆ์Œ

๊ธฐ๋ณธ ์ •๋ณด

  • ๋…ผ๋ฌธ ID: 2501.00767
  • ์ œ๋ชฉ: Infectious diseases, imposing density-dependent mortality on MHC/HLA variation, can account for balancing selection and MHC/HLA polymorphism
  • ์ €์ž: D. P. L. Green
  • ๋ถ„๋ฅ˜: q-bio.PE (์ง‘๋‹จ ๋ฐ ์ง„ํ™”), q-bio.MN (๋ถ„์ž ๋„คํŠธ์›Œํฌ)
  • ๋ฐœํ‘œ ์‹œ๊ฐ„: 2024๋…„ 12์›” 31์ผ
  • ๋…ผ๋ฌธ ๋งํฌ: https://arxiv.org/abs/2501.00767

์ดˆ๋ก

์ธ๊ฐ„ ์ฃผ์š” ์กฐ์ง ์ ํ•ฉ์„ฑ ๋ณตํ•ฉ์ฒด(MHC) ์ด์‹ ์œ ์ „์ž์ขŒ(HLA-A, -B, -C, -DPB1, -DQB1, -DRB1)๋Š” ์ธ๊ฐ„ ๊ฒŒ๋†ˆ์—์„œ ๊ฐ€์žฅ ๋†’์€ ๋‹คํ˜•์„ฑ์„ ๋ณด์ด๋Š” ์˜์—ญ์ด๋‹ค. ์ด๋Ÿฌํ•œ ๋‹คํ˜•์„ฑ์€ ์ ์‘ ๋ฉด์—ญ๊ณ„์— ๋ณ‘์›์ฒด ์œ ๋ž˜ ํŽฉํƒ€์ด๋“œ๋ฅผ ์ œ์‹œํ•˜๋Š” ์—ญํ• ์— ๋ฐ˜์˜๋œ ๊ฒƒ์œผ๋กœ ๋„๋ฆฌ ์ธ์ •๋˜๊ณ  ์žˆ๋‹ค. ํ˜„์žฌ ์ œ์•ˆ๋œ ๋‹คํ˜•์„ฑ ๋ฉ”์ปค๋‹ˆ์ฆ˜์ธ ์Œ์˜ ๋นˆ๋„ ์˜์กด ์„ ํƒ(NFDS)๊ณผ ์ดํ˜• ์ ‘ํ•ฉ ์šฐ์œ„(HA)๋Š” ์ฃผ๋กœ HLA ๋Œ€๋ฆฝ์œ ์ „์ž๊ฐ€ ์•„๋‹Œ ๋‹จ๋ฐฐํ˜•์— ์ดˆ์ ์„ ๋งž์ถ”๊ณ  ์žˆ๋‹ค. ๋ณธ ์—ฐ๊ตฌ๋Š” ๊ฐ์—ผ์„ฑ ์งˆํ™˜์ด HLA ๋‹จ๋ฐฐํ˜•์— ๋…๋ฆฝ์ ์ธ ๋ฐ€๋„ ์˜์กด์  ์กฐ์ ˆ์„ ๋ถ€๊ณผํ•œ๋‹ค๋Š” ์ƒˆ๋กœ์šด ๋ชจ๋ธ์„ ์ œ์•ˆํ•œ๋‹ค. ๊ตฌ์ฒด์ ์œผ๋กœ, ๋ณต์žกํ•œ ๋ณ‘์›์ฒด ํ™˜๊ฒฝ์€ ์ „๋ฌธํ™”๋˜๊ณ  ๋ถˆ์™„์ „ํ•œ ํŽฉํƒ€์ด๋“œ ์ธ์‹์„ ๋‚˜ํƒ€๋‚ด๋Š” HLA ๋‹จ๋ฐฐํ˜• ์ง‘๋‹จ์„ ํ†ตํ•ด ์ˆ™์ฃผ์˜ ๊ด‘๋ฒ”์œ„ํ•œ ๋‹คํ˜•์„ฑ์„ ์ฃผ๋„ํ•œ๋‹ค. ๋‹จ๋ฐฐํ˜• ์ง‘๋‹จ ๊ฐ„์˜ ๋ถ„๋ฆฌ๋Š” ์œ ์‚ฌ์„ฑ ์ œํ•œ์„ ํ†ตํ•ด ์œ ์ง€๋œ๋‹ค. ๊ฒฐ๊ณผ๋Š” ์ •์ƒ ์ƒํƒœ์—์„œ ๊ด‘๋ฒ”์œ„ํ•˜๊ณ  ์•ˆ์ •์ ์ธ ๋‹จ๋ฐฐํ˜• ๋ฐ€๋„ ๋ฒ”์œ„๋ฅผ ์ƒ์„ฑํ•˜๋ฉฐ, ์—ฌ๊ธฐ์„œ ์œ ํšจ Fisher ์ ํ•ฉ๋„๋Š” 0์ด๋‹ค. ๋ฐ€๋„์™€ ๋นˆ๋„๋Š” ์ด๋ก ์ ์œผ๋กœ ์ ํ•ฉ๋„์˜ ๋Œ€์ฒด ์ธก์ •๊ฐ’์ด ๋œ๋‹ค. ๋ฏธ๊ตญ ๊ตญ๋ฆฝ ๊ณจ์ˆ˜ ๊ธฐ์ฆ ํ”„๋กœ๊ทธ๋žจ(NMDP) ๋ฐฑ์ธ HLA ๋ฐ์ดํ„ฐ์…‹ ๋ถ„์„์— ๊ธฐ๋ฐ˜ํ•˜์—ฌ ์ด ๋ชจ๋ธ์€ 350-2000๊ฐœ์˜ ์ƒ์œ„ 5 ์œ ์ „์ž์ขŒ HLA ๋‹จ๋ฐฐํ˜•์˜ ์–‘์˜ ์„ ํƒ์— ๋Œ€ํ•œ ์ฆ๊ฑฐ๋ฅผ ์ œ๊ณตํ•œ๋‹ค. ๋†’์€ ์ ํ•ฉ๋„ ๋‹จ๋ฐฐํ˜•์€ 137๊ฐœ์˜ ๊ณ ๋นˆ๋„ ๋Œ€๋ฆฝ์œ ์ „์ž์˜ ์„ ํƒ์„ ์ฃผ๋„ํ•œ๋‹ค. ์ด๋Ÿฌํ•œ ๋Œ€๋ฆฝ์œ ์ „์ž๋Š” ๋‹จ๋ฐฐํ˜• ํ˜•์„ฑ์—์„œ ์–‘์˜ ์ƒ์œ„์„ฑ๊ณผ ๋‹ค๋ฉด๋ฐœํ˜„์„ ๋‚˜ํƒ€๋‚ด๋ฉฐ, ํ‘œ๋ณธ ์ด์ˆ˜์˜ 97%๋ฅผ ์ฐจ์ง€ํ•˜๋Š” ๊ณ ๋„๋กœ ์ƒํ˜ธ ์—ฐ๊ด€๋œ HLA ๋‹จ๋ฐฐํ˜• ๋„คํŠธ์›Œํฌ๋ฅผ ์ƒ์„ฑํ•œ๋‹ค.

์—ฐ๊ตฌ ๋ฐฐ๊ฒฝ ๋ฐ ๋™๊ธฐ

๋ฌธ์ œ ์ •์˜

HLA ์‹œ์Šคํ…œ์˜ ๊ทน๋‹จ์  ๋‹คํ˜•์„ฑ์€ ์ง„ํ™” ์ƒ๋ฌผํ•™์˜ ๊ณ ์ „์  ๋ฌธ์ œ์ด๋‹ค. ๊ธฐ์กด ์ด๋ก ์€ ์ฃผ๋กœ ๋‹ค์Œ์„ ํฌํ•จํ•œ๋‹ค:

  1. ์Œ์˜ ๋นˆ๋„ ์˜์กด ์„ ํƒ(NFDS): ํฌ๊ท€ ๋Œ€๋ฆฝ์œ ์ „์ž๊ฐ€ ์„ ํƒ ์šฐ์œ„๋ฅผ ๊ฐ€์ง
  2. ์ดํ˜• ์ ‘ํ•ฉ ์šฐ์œ„(HA): ์ดํ˜• ์ ‘ํ•ฉ ๊ฐœ์ฒด๊ฐ€ ๋” ๋†’์€ ์ ํ•ฉ๋„๋ฅผ ๊ฐ€์ง
  3. ํ™˜๊ฒฝ ๋ณ€ํ™”: ์‹œ๊ณต๊ฐ„ ํ™˜๊ฒฝ ๋ณ€ํ™”๊ฐ€ ๋‹คํ˜•์„ฑ์„ ์œ ์ง€ํ•จ

๊ธฐ์กด ๋ฐฉ๋ฒ•์˜ ํ•œ๊ณ„

  1. ๋Œ€๋ฆฝ์œ ์ „์ž๊ฐ€ ์•„๋‹Œ ๋‹จ๋ฐฐํ˜•์— ์ดˆ์ : ๋‹จ๋ฐฐํ˜• ์ˆ˜์ค€์˜ ์„ ํƒ ์••๋ ฅ ๋ฌด์‹œ
  2. ์ธ๊ตฌ ์ƒ๋ฌผํ•™์  ๊ธฐ์ดˆ ๋ถ€์กฑ: ๋ฐ€๋„ ์˜์กด์  ํšจ๊ณผ ๋ฏธ๊ณ ๋ ค
  3. ์ด๋ก ๊ณผ ๋ฐ์ดํ„ฐ ๋ถˆ์ผ์น˜: ๊ด€์ฐฐ๋œ ๋นˆ๋„ ๋ถ„ํฌ ํŒจํ„ด ์„ค๋ช… ๊ณค๋ž€
  4. ๋ณ‘์›์ฒด ์ „ํŒŒ์˜ ์—ญํ•™์  ํŠน์„ฑ ๋ฌด์‹œ: ์งˆ๋ณ‘ ์ „ํŒŒ์˜ ๋ฐ€๋„ ์˜์กด์„ฑ ๋ฏธ๊ณ ๋ ค

์—ฐ๊ตฌ ๋™๊ธฐ

์ €์ž๋Š” ๋‹ค์Œ์„ ์„ค๋ช…ํ•  ์ˆ˜ ์žˆ๋Š” ์ƒˆ๋กœ์šด ์ด๋ก ์  ํ‹€์˜ ํ•„์š”์„ฑ์„ ์ œ์‹œํ•œ๋‹ค:

  • HLA ๋Œ€๋ฆฝ์œ ์ „์ž ๋ฐ ๋‹จ๋ฐฐํ˜•์˜ ๋‘๊บผ์šด ๊ผฌ๋ฆฌ ๋นˆ๋„ ๋ถ„ํฌ
  • ๊ณ ๋นˆ๋„ ๋‹จ๋ฐฐํ˜•์˜ ์–‘์˜ ์—ฐ์‡„ ๋ถ€๋“ฑํ‰ํ˜•
  • ์ผ๋ฐ˜์ ์ธ 5 ์œ ์ „์ž์ขŒ ๋‹จ๋ฐฐํ˜•์˜ ๊ณผ๋„ํ•œ ๋™ํ˜• ์ ‘ํ•ฉ์„ฑ
  • ์ข…๊ฐ„ ๋‹คํ˜•์„ฑ์˜ ์žฅ๊ธฐ ์œ ์ง€

ํ•ต์‹ฌ ๊ธฐ์—ฌ

  1. ๋ฐ€๋„ ์˜์กด์  ์กฐ์ ˆ ๋ชจ๋ธ ์ œ์•ˆ: ๊ฐ์—ผ์„ฑ ์งˆํ™˜์„ HLA ๋‹จ๋ฐฐํ˜• ๋ฐ€๋„ ์˜์กด์  ์‚ฌ๋ง๋ฅ ์˜ ์›์ฒœ์œผ๋กœ ์ œ์‹œ
  2. ๋‹จ๋ฐฐํ˜• ์„ ํƒ ์ด๋ก  ์ˆ˜๋ฆฝ: ์„ ํƒ์ด ์ฃผ๋กœ ๋Œ€๋ฆฝ์œ ์ „์ž๊ฐ€ ์•„๋‹Œ ๋‹จ๋ฐฐํ˜• ์ˆ˜์ค€์—์„œ ์ž‘์šฉํ•จ์„ ์ฆ๋ช…
  3. HLA ๋„คํŠธ์›Œํฌ ๊ตฌ์กฐ ๋ฐœ๊ฒฌ: 137๊ฐœ ํ•ต์‹ฌ ๋Œ€๋ฆฝ์œ ์ „์ž๋กœ ๊ตฌ์„ฑ๋œ ๊ณ ๋„๋กœ ์ƒํ˜ธ ์—ฐ๊ด€๋œ ๋„คํŠธ์›Œํฌ ์‹๋ณ„
  4. ์‹ค์ฆ์  ์ง€์› ์ œ๊ณต: NMDP ๋Œ€๊ทœ๋ชจ ๋ฐ์ดํ„ฐ์…‹์„ ๊ธฐ๋ฐ˜์œผ๋กœ ์ด๋ก ์  ์˜ˆ์ธก ๊ฒ€์ฆ
  5. ๊ท ํ˜• ์„ ํƒ์˜ ์žฌ์ •์˜: ๊ท ํ˜• ์„ ํƒ์„ ๋ฐ€๋„ ์˜์กด์  ์กฐ์ ˆ์˜ ๊ฒฐ๊ณผ๋กœ ํ•ด์„

๋ฐฉ๋ฒ•๋ก  ์ƒ์„ธ ์„ค๋ช…

์ด๋ก ์  ํ‹€

๋ฐ€๋„ ์˜์กด์  ์กฐ์ ˆ ๋ชจ๋ธ

Verhulst ๋กœ์ง€์Šคํ‹ฑ ๋ฐฉ์ •์‹ ๋ฐ Anderson-May ์งˆ๋ณ‘ ์ „ํŒŒ ๋ฐฉ์ •์‹์— ๊ธฐ๋ฐ˜:

dN/dt = rN - ฮฑNยฒ

์—ฌ๊ธฐ์„œ:

  • N: ๋‹จ๋ฐฐํ˜• ๋ฐ€๋„
  • r: ๋‚ด์žฌ ์ฆ๊ฐ€์œจ(Fisher ์ ํ•ฉ๋„)
  • ฮฑ: ๋ฐ€๋„ ์˜์กด์  ์‚ฌ๋ง๋ฅ  ๊ณ„์ˆ˜

์ •์ƒ ์ƒํƒœ ์กฐ๊ฑด

์ •์ƒ ์ƒํƒœ์—์„œ(dN/dt = 0):

r = ฮฑN*

์—ฌ๋Ÿฌ ๋‹จ๋ฐฐํ˜•์˜ ๊ณต์กด:

ฮฑโ‚Nโ‚* = ฮฑโ‚‚Nโ‚‚* = ... = ฮฑแตขNแตข* = rฬƒ

Neher-Shraiman ๋ชจ๋ธ ํ™•์žฅ

๋‹จ๋ฐฐํ˜• ์ ํ•ฉ๋„๋ฅผ ๋‹ค์Œ๊ณผ ๊ฐ™์ด ๋ถ„ํ•ด:

F = E + A

์—ฌ๊ธฐ์„œ E๋Š” ์ƒ์œ„์„ฑ ์„ฑ๋ถ„, A๋Š” ๊ฐ€์‚ฐ ์„ฑ๋ถ„์ด๋‹ค.

๋ฐ์ดํ„ฐ ๋ถ„์„ ๋ฐฉ๋ฒ•

๋กœ๊ทธ-๋กœ๊ทธ ์ˆœ์œ„-๋นˆ๋„ ๋ถ„์„

Belevitch ์–ธ์–ดํ•™ ๋ถ„์„ ๋ฐฉ๋ฒ• ์‚ฌ์šฉ:

log(pแตข/pโ‚€) = -A log(i/iโ‚€)

๋„คํŠธ์›Œํฌ ๋ถ„์„

  • ๊ณ ๋นˆ๋„ ๋Œ€๋ฆฝ์œ ์ „์ž์˜ ๋‹ค๋ฉด๋ฐœํ˜„ ํŒจํ„ด ์‹๋ณ„
  • ๋‹จ๋ฐฐํ˜• ๊ฐ„ ์—ฐ๊ฒฐ๋„ ๋ถ„์„
  • ์ƒ์œ„์„ฑ ํšจ๊ณผ ์ •๋Ÿ‰ํ™”

์‹คํ—˜ ์„ค์ •

๋ฐ์ดํ„ฐ์…‹

  • NMDP ๋ฐฑ์ธ ๋ฐ์ดํ„ฐ์…‹: ~10โต๊ฐœ ๊ฐœ์ฒด์˜ 5 ์œ ์ „์ž์ขŒ HLA ๋‹จ๋ฐฐํ˜• ๋ฐ์ดํ„ฐ ํฌํ•จ
  • ์ปค๋ฒ„ ์œ ์ „์ž์ขŒ: HLA-A, -B, -C, -DRB1, -DQB1
  • ํ‘œ๋ณธ ๊ทœ๋ชจ: 85,000๊ฐœ ๋‹จ๋ฐฐํ˜•, 6๊ฐœ ์ˆ˜๋Ÿ‰๊ธ‰ ๋ฒ”์œ„์˜ ๋นˆ๋„

๋ถ„์„ ์ง€ํ‘œ

  • ์ˆœ์œ„-๋นˆ๋„ ๋ถ„ํฌ ํŒจํ„ด
  • ์—ฐ์‡„ ๋ถ€๋“ฑํ‰ํ˜•(D')
  • Shannon ์—”ํŠธ๋กœํ”ผ
  • ์ƒ์œ„์„ฑ ํšจ๊ณผ ํฌ๊ธฐ

๋น„๊ต ๋ถ„์„

  • ์‹ค์ œ ๋นˆ๋„ vs ์˜ˆ์ƒ ๋นˆ๋„(๋Œ€๋ฆฝ์œ ์ „์ž ๋นˆ๋„ ๊ณฑ์— ๊ธฐ๋ฐ˜)
  • ๊ณ ๋นˆ๋„ vs ์ €๋นˆ๋„ ๋‹จ๋ฐฐํ˜•์˜ ์—ฐ์‡„ ๋ถ€๋“ฑํ‰ํ˜• ํŒจํ„ด
  • ํ•ต์‹ฌ ๋Œ€๋ฆฝ์œ ์ „์ž vs ํฌ๊ท€ ๋Œ€๋ฆฝ์œ ์ „์ž์˜ ๋ถ„ํฌ

์‹คํ—˜ ๊ฒฐ๊ณผ

์ฃผ์š” ๋ฐœ๊ฒฌ

1. ์ด๋ด‰ํ˜• ๋‹จ๋ฐฐํ˜• ๋ถ„ํฌ

  • ์„ ํƒ ์ง‘๋‹จ: 350-2000๊ฐœ ๊ณ ๋นˆ๋„ ๋‹จ๋ฐฐํ˜•(ํ‘œ๋ณธ์˜ 80%)
  • ์ค‘๋ฆฝ/์Œ์˜ ์„ ํƒ ์ง‘๋‹จ: ์ €๋นˆ๋„ ๋‹จ๋ฐฐํ˜•(ํ‘œ๋ณธ์˜ 20%)
  • ์ „ํ™˜์ : ์•ฝ 1730๋ฒˆ์งธ

2. ํ•ต์‹ฌ ๋Œ€๋ฆฝ์œ ์ „์ž ๋„คํŠธ์›Œํฌ

137๊ฐœ ํ•ต์‹ฌ ๋Œ€๋ฆฝ์œ ์ „์ž ์‹๋ณ„:

  • HLA-A: 30๊ฐœ ๋Œ€๋ฆฝ์œ ์ „์ž(๋ˆ„์  ๋นˆ๋„ 99.7%)
  • HLA-B: 40๊ฐœ ๋Œ€๋ฆฝ์œ ์ „์ž(๋ˆ„์  ๋นˆ๋„ 98.6%)
  • HLA-C: 20๊ฐœ ๋Œ€๋ฆฝ์œ ์ „์ž(๋ˆ„์  ๋นˆ๋„ 99.6%)
  • HLA-DQB1: 15๊ฐœ ๋Œ€๋ฆฝ์œ ์ „์ž(๋ˆ„์  ๋นˆ๋„ 99.9%)
  • HLA-DRB1: 31๊ฐœ ๋Œ€๋ฆฝ์œ ์ „์ž(๋ˆ„์  ๋นˆ๋„ 99.3%)

3. ๋ฉฑ๋ฒ•์น™ ๋ถ„ํฌ ํŠน์„ฑ

๊ณ ๋นˆ๋„ ๋‹จ๋ฐฐํ˜•์€ ๋ฉฑ๋ฒ•์น™ ๋ถ„ํฌ๋ฅผ ๋”ฐ๋ฆ„:

y = 0.0506x^(-0.822)

4. ์–‘์˜ ์ƒ์œ„์„ฑ ์ฆ๊ฑฐ

  • ์‹ค์ œ ๋‹จ๋ฐฐํ˜• ๋นˆ๋„๋Š” 5๊ฐœ ์ˆ˜๋Ÿ‰๊ธ‰ ๋ฒ”์œ„
  • ์˜ˆ์ƒ ๋นˆ๋„(๋Œ€๋ฆฝ์œ ์ „์ž ๋นˆ๋„ ๊ณฑ์— ๊ธฐ๋ฐ˜)๋Š” 1๊ฐœ ์ˆ˜๋Ÿ‰๊ธ‰ ๋ฒ”์œ„๋งŒ
  • ์ƒ์œ„์„ฑ ์„ฑ๋ถ„์€ ๊ณ ๋นˆ๋„ ๋Œ€๋ฆฝ์œ ์ „์ž ๋นˆ๋„์˜ 9-12% ์ฐจ์ง€

์Šˆํผํƒ€์ž… ๋ถ„์„

ํ•ต์‹ฌ ๋Œ€๋ฆฝ์œ ์ „์ž๋ฅผ HLA ์Šˆํผํƒ€์ž…์— ๋งคํ•‘:

  • ๊ณ ๋Œ€ ํ•ต์‹ฌ ๋Œ€๋ฆฝ์œ ์ „์ž(๋„ค์•ˆ๋ฐ๋ฅดํƒˆ์ธ/๋ฐ๋‹ˆ์†Œ๋ฐ”์ธ ์œ ๋ž˜ ๊ฐ€๋Šฅ)๊ฐ€ ๊ณ ๋นˆ๋„ ๋Œ€๋ฆฝ์œ ์ „์ž์—์„œ ์šฐ์œ„
  • ์Šˆํผํƒ€์ž… ๋‚ด๋ถ€๋Š” ๊ฒฝ์Ÿ ๋ฐฐ์ œ ํŒจํ„ด ๋‚˜ํƒ€๋ƒ„
  • ์Šˆํผํƒ€์ž… ๊ฐ„์€ ์œ ์‚ฌ์„ฑ ์ œํ•œ ๋‚˜ํƒ€๋ƒ„

์žฅ๊ฑฐ๋ฆฌ ์—ฐ์‡„ ๋ถ„์„

HLA-B~DRB1 ์Œ ๋ถ„์„ ๊ฒฐ๊ณผ:

  • 1240๊ฐœ ๊ฐ€๋Šฅํ•œ ์Œ ์ค‘ ์•ฝ 250๊ฐœ(20%)๊ฐ€ ์„ ํƒ ์••๋ ฅ ํ•˜์— ์žˆ์Œ
  • ๋‘ ๊ฐœ์˜ ์ฃผ์š” ์Œ: B08:01g/DRB103:01g(8%)๊ณผ B07:02/DRB115:01(6.9%)

์ด๋ก ์  ์˜์˜ ๋ฐ ๋…ผ์˜

๊ท ํ˜• ์„ ํƒ ์ด๋ก ์˜ ์žฌ๊ฒ€ํ† 

์ „ํ†ต ์ด๋ก ์˜ ํ•œ๊ณ„

  1. ์ดํ˜• ์ ‘ํ•ฉ ์šฐ์œ„: ๋ชจ๋“  ๋Œ€๋ฆฝ์œ ์ „์ž๊ฐ€ ๊ทผ์‚ฌ์ ์œผ๋กœ ๋™๋“ฑํ•œ ์ ํ•ฉ๋„๋ฅผ ์š”๊ตฌํ•˜๋ฉฐ, ๊ด€์ฐฐ๊ณผ ๋ถˆ์ผ์น˜
  2. ์Œ์˜ ๋นˆ๋„ ์˜์กด ์„ ํƒ: ์˜ˆ์ธก๋œ ๋Œ€๋ฆฝ์œ ์ „์ž ๊ต์ฒด ์†๋„๊ฐ€ ๋„ˆ๋ฌด ๋น ๋ฅด๋ฉฐ, ์ข…๊ฐ„ ๋‹คํ˜•์„ฑ ์„ค๋ช… ๋ถˆ๊ฐ€
  3. ์—ญํ•™ ๋ฌด์‹œ: ์งˆ๋ณ‘ ์ „ํŒŒ์˜ ๋ฐ€๋„ ์˜์กด์  ํŠน์„ฑ ๋ฏธ๊ณ ๋ ค

์ƒˆ๋กœ์šด ๋ชจ๋ธ์˜ ์žฅ์ 

  1. ๋ฐ€๋„ ์˜์กด์  ์กฐ์ ˆ: ์ž๋™์œผ๋กœ 0์˜ ์œ ํšจ ์ ํ•ฉ๋„๋ฅผ ์ƒ์„ฑํ•˜์—ฌ ์•ˆ์ •์  ๊ณต์กด ์‹คํ˜„
  2. ๋‹จ๋ฐฐํ˜• ์„ ํƒ: ๊ด€์ฐฐ๋œ ์—ฐ์‡„ ๋ถ€๋“ฑํ‰ํ˜• ํŒจํ„ด์„ ๋” ์ž˜ ์„ค๋ช…
  3. ๋„คํŠธ์›Œํฌ ํšจ๊ณผ: ๋Œ€๋ฆฝ์œ ์ „์ž ๋‹ค๋ฉด๋ฐœํ˜„ ๋ฐ ๋‹จ๋ฐฐํ˜• ์ƒํ˜ธ ์—ฐ๊ด€์„ฑ ์„ค๋ช…

์ง„ํ™” ์ „๋žต ์œ ์ถ”

"์—๋‹ˆ๊ทธ๋งˆ ์•”ํ˜ธ๊ธฐ" ์œ ์ถ”

HLA ์‹œ์Šคํ…œ์€ 2์ฐจ ์„ธ๊ณ„๋Œ€์ „ ์—๋‹ˆ๊ทธ๋งˆ ์•”ํ˜ธ๊ธฐ์™€ ์œ ์‚ฌ:

  • ๋‹ค์ค‘ ๋กœํ„ฐ ์„ค๊ณ„: ๋‹ค์ค‘ ์œ ์ „์ž์ขŒ ๋‹จ๋ฐฐํ˜•์ด ํ•ด๋… ๋‚œ์ด๋„ ์ฆ๊ฐ€
  • ์„ค์ • ๋ถ„์‚ฐ: ๋‹คํ˜•์„ฑ์ด ๋ณ‘์›์ฒด ๋ŒํŒŒ์˜ ์˜ํ–ฅ ๋ฒ”์œ„ ์ œํ•œ
  • ๊ด‘๋ฒ”์œ„ ์ €์นœํ™”๋ ฅ: ํ•ญ์ฒด ๊ณ ์นœํ™”๋ ฅ ์ „๋žต๊ณผ ๋Œ€์กฐ

Red Queen ๋™์—ญํ•™

  • ๋ณ‘์›์ฒด: ๋น ๋ฅธ ๋ฒˆ์‹, ๋†’์€ ๋Œ์—ฐ๋ณ€์ด์œจ
  • ์ˆ™์ฃผ ๋ฐฉ์–ด: ์ƒ๋Œ€์ ์œผ๋กœ ์•ˆ์ •์ ์ธ ์ œ์‹œ ์‹œ์Šคํ…œ + ๋น ๋ฅธ T์„ธํฌ ํ™•๋Œ€ ๋ฐ˜์‘
  • ๊ท ํ˜•์ : ๋‹จ๋ฐฐํ˜• ๋„คํŠธ์›Œํฌ๋ฅผ ํ†ตํ•ด ๋ฐฉ์–ด ๋‹ค์–‘ํ™” ์‹คํ˜„

์ค€์ข… ํŠน์„ฑ

HLA ๋„คํŠธ์›Œํฌ๋Š” ์ค€์ข… ํŠน์„ฑ์„ ๋‚˜ํƒ€๋ƒ„:

  • ๊ณ ๋„ ์ƒํ˜ธ ์—ฐ๊ด€: ๋Œ€๋ฆฝ์œ ์ „์ž ๋‹ค๋ฉด๋ฐœํ˜„์„ ํ†ตํ•ด ์—ฐ๊ฒฐ
  • ๋„คํŠธ์›Œํฌ ์„ ํƒ: ๋‹จ์ผ ๋‹จ๋ฐฐํ˜•์ด ์•„๋‹Œ ์ „์ฒด ๋„คํŠธ์›Œํฌ๊ฐ€ ์„ ํƒ ์••๋ ฅ ํ•˜์— ์žˆ์Œ
  • ์•ˆ์ •์„ฑ: ๋ฐ€๋„ ์˜์กด์  ์กฐ์ ˆ์„ ํ†ตํ•ด ์œ ์ง€

ํ•œ๊ณ„ ๋ฐ ํ–ฅํ›„ ๋ฐฉํ–ฅ

ํ˜„์žฌ ํ•œ๊ณ„

  1. ์ƒ์œ„์„ฑ ๋ฉ”์ปค๋‹ˆ์ฆ˜ ๋ฏธ๋ช…ํ™•: ์–‘์˜ ์ƒ์œ„์„ฑ์˜ ๊ตฌ์ฒด์  ๋ถ„์ž ๋ฉ”์ปค๋‹ˆ์ฆ˜ ์ถ”๊ฐ€ ๊ทœ๋ช… ํ•„์š”
  2. ์‹œ๊ฐ„ ์ฒ™๋„ ๋ฌธ์ œ: ๋„คํŠธ์›Œํฌ ์•ˆ์ •์„ฑ์˜ ์‹œ๊ฐ„ ์ฒ™๋„ ์ถ”๊ฐ€ ์—ญ์‚ฌ ๋ฐ์ดํ„ฐ ๊ฒ€์ฆ ํ•„์š”
  3. ์ง‘๋‹จ ํŠน์ด์„ฑ: ์ฃผ๋กœ ๋ฐฑ์ธ ์ง‘๋‹จ ๋ฐ์ดํ„ฐ์— ๊ธฐ๋ฐ˜ํ•˜๋ฉฐ, ๋‹ค๋ฅธ ์ง‘๋‹จ์œผ๋กœ ํ™•์žฅ ํ•„์š”
  4. ๋ณ‘์›์ฒด ๋ฐ์ดํ„ฐ ๋ถ€์กฑ: ์ฒด๊ณ„์ ์ธ ๋ณ‘์›์ฒด-HLA ์ƒํ˜ธ์ž‘์šฉ ํ–‰๋ ฌ ๋ถ€์žฌ

ํ–ฅํ›„ ์—ฐ๊ตฌ ๋ฐฉํ–ฅ

  1. ๊ธฐ๋Šฅ ๊ฒ€์ฆ: AlphaFold ๋“ฑ ๊ตฌ์กฐ ์˜ˆ์ธก ๋„๊ตฌ๋ฅผ ์‚ฌ์šฉํ•œ ์ƒ์œ„์„ฑ ๋ฉ”์ปค๋‹ˆ์ฆ˜ ์—ฐ๊ตฌ
  2. ์ข…๊ฐ„ ๋น„๊ต: ๋‹ค์–‘ํ•œ ์ง‘๋‹จ์˜ HLA ๋„คํŠธ์›Œํฌ ๊ธฐ๋Šฅ ์ค‘๋ณต ๋ถ„์„
  3. ์—ญ์‚ฌ์  ์•ˆ์ •์„ฑ: ๊ณ ๋Œ€ DNA ๋ฐ์ดํ„ฐ๋ฅผ ํ™œ์šฉํ•œ ๋„คํŠธ์›Œํฌ ๋นˆ๋„ ์•ˆ์ •์„ฑ ๊ฒ€์ฆ
  4. ๊ฐ์—ผ ํ–‰๋ ฌ: ๋ณ‘์›์ฒด ํŽฉํƒ€์ด๋“œ-HLA ๋‹จ๋ฐฐํ˜• ์ธ์‹ ํ–‰๋ ฌ ๊ตฌ์ถ•

์‹ฌ์ธต ํ‰๊ฐ€

์žฅ์ 

  1. ์ด๋ก ์  ํ˜์‹ : ๋ฐ€๋„ ์˜์กด์  ์กฐ์ ˆ์„ HLA ๋‹คํ˜•์„ฑ ์„ค๋ช…์— ์ฒ˜์Œ ๋„์ž…
  2. ์ถฉ๋ถ„ํ•œ ๋ฐ์ดํ„ฐ ์ง€์›: NMDP ๋Œ€๊ทœ๋ชจ ๋ฐ์ดํ„ฐ์…‹ ๊ธฐ๋ฐ˜ ์ฒด๊ณ„์  ๋ถ„์„
  3. ํ•™์ œ๊ฐ„ ํ†ตํ•ฉ: ์ธ๊ตฌ ์ƒ๋ฌผํ•™, ์—ญํ•™ ๋ฐ ๋ฉด์—ญ ์œ ์ „ํ•™ ์„ฑ๊ณต์  ํ†ตํ•ฉ
  4. ๊ฐ•ํ•œ ์„ค๋ช…๋ ฅ: ์—ฌ๋Ÿฌ ์žฅ๊ธฐ ์กด์žฌ ๊ด€์ฐฐ ํ˜„์ƒ์˜ ํ†ต์ผ์  ์„ค๋ช…

๋ถ€์กฑํ•œ ์ 

  1. ๋ฉ”์ปค๋‹ˆ์ฆ˜ ์„ธ๋ถ€์‚ฌํ•ญ: ์ƒ์œ„์„ฑ์˜ ๋ถ„์ž ๊ธฐ์ดˆ ์—ฌ์ „ํžˆ ์‹คํ—˜ ๊ฒ€์ฆ ํ•„์š”
  2. ๋ชจ๋ธ ๋‹จ์ˆœํ™”: ๋ณ‘์›์ฒด ํ™˜๊ฒฝ์˜ ๋ณต์žก์„ฑ์ด ๊ณผ๋„ํ•˜๊ฒŒ ๋‹จ์ˆœํ™”๋  ์ˆ˜ ์žˆ์Œ
  3. ์˜ˆ์ธก ๋Šฅ๋ ฅ: ํ–ฅํ›„ ์ง„ํ™” ๋™์—ญํ•™์— ๋Œ€ํ•œ ๋ชจ๋ธ์˜ ์˜ˆ์ธก ๋Šฅ๋ ฅ ๊ฒ€์ฆ ํ•„์š”

์˜ํ–ฅ๋ ฅ ํ‰๊ฐ€

๋ณธ ์—ฐ๊ตฌ๋Š” ๋‹ค์Œ ๋ถ„์•ผ์— ์ค‘์š”ํ•œ ์˜ํ–ฅ์„ ๋ฏธ์น  ์ˆ˜ ์žˆ๋‹ค:

  1. ์ง„ํ™” ๋ฉด์—ญํ•™: MHC ์ง„ํ™”์˜ ์ด๋ก ์  ํ‹€ ์žฌ์ •์˜
  2. ๊ฐœ์ธ๋งž์ถค ์˜ํ•™: HLA ๊ธฐ๋ฐ˜ ์งˆ๋ณ‘ ๊ฐ์ˆ˜์„ฑ ์˜ˆ์ธก์— ์ƒˆ๋กœ์šด ๊ด€์  ์ œ๊ณต
  3. ๋ฐฑ์‹  ์„ค๊ณ„: ์ธ๊ตฌ HLA ๋‹ค์–‘์„ฑ์„ ๊ณ ๋ คํ•œ ๋ฐฑ์‹  ๊ฐœ๋ฐœ ์ „๋žต ์ง€๋„

์ ์šฉ ์‹œ๋‚˜๋ฆฌ์˜ค

  • MHC/HLA ๋‹คํ˜•์„ฑ์˜ ์ง„ํ™” ๋ถ„์„
  • ์ธ๊ตฌ ๋ฉด์—ญ ์œ ์ „ํ•™ ์—ฐ๊ตฌ
  • ๊ฐ์—ผ๋ณ‘ ์—ญํ•™ ๋ชจ๋ธ๋ง
  • ๊ฐœ์ธ๋งž์ถค ๋ฉด์—ญ ์น˜๋ฃŒ ์„ค๊ณ„

๊ฒฐ๋ก 

๋ณธ ์—ฐ๊ตฌ๋Š” HLA ๋‹คํ˜•์„ฑ์„ ๋ณ‘์›์ฒด๊ฐ€ ๋ถ€๊ณผํ•˜๋Š” ๋ฐ€๋„ ์˜์กด์  ์„ ํƒ์˜ ๊ฒฐ๊ณผ๋กœ ์„ค๋ช…ํ•˜๋Š” ํ˜์‹ ์  ์ด๋ก ์  ํ‹€์„ ์ œ์‹œํ•œ๋‹ค. ๋Œ€๊ทœ๋ชจ ๋ฐ์ดํ„ฐ ๋ถ„์„์„ ํ†ตํ•ด ์ €์ž๋Š” HLA ์‹œ์Šคํ…œ์ด 137๊ฐœ ํ•ต์‹ฌ ๋Œ€๋ฆฝ์œ ์ „์ž๋กœ ๊ตฌ์„ฑ๋œ ๊ณ ๋„๋กœ ์ƒํ˜ธ ์—ฐ๊ด€๋œ ๋„คํŠธ์›Œํฌ๋ฅผ ํ˜•์„ฑํ•˜๋ฉฐ, ์ด ๋„คํŠธ์›Œํฌ๋Š” ์–‘์˜ ์ƒ์œ„์„ฑ๊ณผ ๋‹ค๋ฉด๋ฐœํ˜„์„ ํ†ตํ•ด ์•ˆ์ •์ ์ธ ๋‹คํ˜•์„ฑ์„ ์œ ์ง€ํ•จ์„ ๋ฐœ๊ฒฌํ–ˆ๋‹ค. ์ด ๋ฐœ๊ฒฌ์€ MHC ์ง„ํ™” ์ดํ•ด์— ์ƒˆ๋กœ์šด ๊ด€์ ์„ ์ œ๊ณตํ•  ๋ฟ๋งŒ ์•„๋‹ˆ๋ผ ๊ด€๋ จ ์˜ํ•™ ์‘์šฉ์„ ์œ„ํ•œ ์ด๋ก ์  ๊ธฐ์ดˆ๋ฅผ ๋งˆ๋ จํ•œ๋‹ค.